2022
DOI: 10.1002/prp2.1049
|View full text |Cite
|
Sign up to set email alerts
|

MG53: A potential therapeutic target for kidney disease

Abstract: Ensuring cell survival and tissue regeneration by maintaining cellular integrity is important to the pathophysiology of many human diseases, including kidney disease. Mitsugumin 53 (MG53) is a member of the tripartite motif‐containing (TRIM) protein family that plays an essential role in repairing cell membrane injury and improving tissue regeneration. In recent years, an increasing number of studies have demonstrated that MG53 plays a renoprotective role in kidney diseases. Moreover, with the beneficial effec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 69 publications
(172 reference statements)
0
2
0
Order By: Relevance
“…7 It has been documented that MG53 has a protective effect against the pathogenesis of multiple inflammatory diseases. 8,9 MG53 predominantly contributes to cardioprotection in cardiac diseases through regulating several cell signaling pathways, such as phosphatidylinositol 3-kinase-protein kinase B (PI3K) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) signaling pathways. 28 Moreover, accumulating evidence showed that systemic cell infiltration and mucus secretion were aggravated in lung tissues but were attenuated by MG53 intervention (Figures 2B and 2C).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…7 It has been documented that MG53 has a protective effect against the pathogenesis of multiple inflammatory diseases. 8,9 MG53 predominantly contributes to cardioprotection in cardiac diseases through regulating several cell signaling pathways, such as phosphatidylinositol 3-kinase-protein kinase B (PI3K) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) signaling pathways. 28 Moreover, accumulating evidence showed that systemic cell infiltration and mucus secretion were aggravated in lung tissues but were attenuated by MG53 intervention (Figures 2B and 2C).…”
Section: Discussionmentioning
confidence: 99%
“…7 Recently, more studies have shown that MG53 acts as a protective agent in the kidney and cardiac diseases. 8,9 In addition, a wide range of human diseases, such as diabetes mellitus and lung cancer, are regulated by MG53. Further, studies have documented that MG53 is involved in a variety of physiological and pathological processes, such as the suppression of aberrant intracellular Ca 2+ signaling, insulin resistance, inhibition of inflammation, suppression of cell apoptosis, reduction of oxidative stress, and wound healing.…”
Section: Introductionmentioning
confidence: 99%